Article Text

PDF
News and updates from palliativedrugs.com
  1. Andrew Wilcock1 and
  2. Sarah Charlesworth2
  1. 1Department of Palliative Medicine, University of Nottingham, Nottingham, UK
  2. 2Palliativedrugs.com, Nottingham, UK
  1. Correspondence to Dr Andrew Wilcock, Department of Palliative Medicine, University of Nottingham, Hayward House, Nottingham University Hospitals NHS Trust, Nottingham, UK; andrew.wilcock{at}nottingham.ac.uk

Statistics from Altmetric.com

www.palliativedrugs.com has provided essential independent information about drugs used in palliative and hospice care for over a decade. It provides access to the Palliative Care Formulary, a Bulletin Board to stimulate questions and share experiences, a Document Library of guidelines and other useful information and a Syringe Driver Drug Database containing details of over 1000 different drug combinations. Territory-specific book versions (the UK Palliative Care Formulary 4th edition, Hospice and Palliative Care Formulary USA 2nd edition and Palliative Care Formulary Canadian edition) can also be purchased on the website. This feature provides a selection of items that have appeared in the News and Latest Additions sections in recent months; for additional information please register for free on the website.

Latest from the UK National Patient Safety Agency (NPSA)

NPSA rapid response report on syringe drivers

In response to over 160 error reports and 8 deaths in the past 5 years, the NPSA has issued a rapid response report on the safer use of ambulatory syringe drivers. Errors were more likely in older drivers with rate settings measured in terms of the length of syringe plunger travel. All organisations in the NHS and independent sector must develop an action plan to ensure that all ambulatory syringe drivers comply with …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.